Abstract: A tuned mass damper (TMD) system in combination with a floating offshore wind turbine (FOWT) platform includes a barge type FOWT platform having a hull configured to have a wind turbine tower mounted thereon. A TMD system is mounted in the hull and has a first TMD configured to operate at a first frequency, and a second TMD configured to operate at a second frequency different than the first frequency.

Abstract: The invention describes a method and a walk through apparatus to treat surfaces with hydroxyl ions to reduce the viability and/or kill pathogens.

Abstract: Disclosed are various synthetic methods to prepare structural analogs of largazole and derivatives thereof. One structural analog is an amide isostere of largazole. Another structural analog replaces the thiazole ring of largazole with a pyridine moiety or an oxazole moiety.

Abstract: An internal boss can have an outer side surface shaped to match the bored opening of the Drain, Waste, and Vent (DWV) pipe, an inner side surface shaped to align with an interior pipe surface of the sanitary Tee or Wye fitting component, and an internal face surface of the boss extending between the side surfaces and shaped to align with an interior pipe surface of the DWV pipe when welded thereto. Snap-fit wings can hold the interior face surface of the sanitary Tee or Wye fitting component against an exterior face surface of the DWV pipe while the fitting component and DWV pipe are homogeneously weldable into a single DWV fitting using a solvent mixture including a common plastic material. Related methods and single homogeneous fittings are also provided.

Abstract: Analogs of largazole are described herein. Methods of treating cancer and blood disorders using largazole and largazole analogs and pharmaceutical compositions comprising the same are additionally described herein. Methods for preparing largazole analogs are likewise described.

Abstract: The present invention relates to a method of making a paper product having Improved printing characteristics. This is achieved by forming a fibrous substrate, and applying a surface treatment which comprises an aqueous composition. Notably, the aqueous composition includes surface enhanced pulp fibers, with the placement of the surface enhanced pulp fibers optimizing their functionality, with surface placement by use of a paper machine size press desirably facilitating a reduction in the typical starch usage. The present method comprising the steps of providing a aqueous slurry comprising a blend of cellulosic fibers and water and dewatering the aqueous slurry of cellulosic fibers and water to form a fibrous substrate.

Abstract: Analogs of largazole are described herein. Methods of treating cancer, blood disorders, autoimmune disease, and Alzheimer's Disease using largazole analogs and pharmaceutical compositions comprising the same are additionally described herein. Methods for preparing largazole analogs are likewise described.

Abstract: The present invention relates to a method of making a paper product having Improved printing characteristics. This is achieved by forming a fibrous substrate, and applying a surface treatment which comprises an aqueous composition. Notably, the aqueous composition includes surface enhanced pulp fibers, with the placement of the surface enhanced pulp fibers optimizing their functionality, with surface placement by use of a paper machine size press desirably facilitating a reduction in the typical starch usage. The present method comprising the steps of providing a aqueous slurry comprising a blend of cellulosic fibers and water and dewatering the aqueous slurry of cellulosic fibers and water to form a fibrous substrate.

Abstract: An internal boss can have an outer side surface shaped to match the bored opening of the DWV pipe, an inner side surface shaped to align with an interior pipe surface of the sanitary Tee or Wye fitting component, and an internal face surface of the boss extending between the side surfaces and shaped to align with an interior pipe surface of the DWV pipe when welded thereto. Snap-fit wings can hold the interior face surface of the sanitary Tee or Wye fitting component against an exterior face surface of the DWV pipe while the fitting component and DWV pipe are homogeneously weldable into a single DWV fitting using a solvent mixture including a common plastic material. Related methods and single homogeneous fittings are also provided.

Abstract: The present invention relates to a method of making a paper product having improved printing characteristics. This is achieved by forming a fibrous substrate, and applying a surface treatment which comprises an aqueous composition. Notably, the aqueous composition includes surface enhanced pulp fibers, with the placement of the surface enhanced pulp fibers optimizing their functionality, with surface placement by use of a paper machine size press desirably facilitating a reduction in the typical starch usage. The present method comprising the steps of providing a aqueous slurry comprising a blend of cellulosic fibers and water and dewatering the aqueous slurry of cellulosic fibers and water to form a fibrous substrate.

Abstract: Analogs of largazole are described herein. Methods of treating cancer, blood disorders, autoimmune disease, and Alzheimer's Disease using largazole analogs and pharmaceutical compositions comprising the same are additionally described herein. Methods for preparing largazole analogs are likewise described.

Abstract: Analogs of largazole are described herein. Methods of treating cancer and blood disorders using largazole and largazole analogs and pharmaceutical compositions comprising the same are additionally described herein. Methods for preparing largazole analogs are likewise described.

Abstract: The invention is directed to compounds that are specific inhibitors of PKC delta, and methods and compositions for the treatment and prevention of cancers and other disorders. Compositions comprising compounds of the invention are used to treat cancers such as, for example, carcinoid and neuroendocrine tumors, malignant melanomas, pancreatic, gastrointestinal and lung cancers. Neuroendocrine tumor cell lines of pulmonary and gastrointestinal origin are surprisingly sensitive to PKC delta inhibition by the compounds of the invention. The invention is further directed to methods, compositions and kits containing compounds of the formulas (Ia), (IIa), (IIIa), (IVa), and (V) as disclosed and described in FIGS. 11 and 12.

Abstract: The invention is directed to compounds that are specific inhibitors of PKC delta, and methods and compositions for the treatment and prevention of cancers and other disorders. Compositions comprising compounds of the invention are used to treat cancers such as, for example, carcinoid and neuroendocrine tumors, malignant melanomas, pancreatic, gastrointestinal and lung cancers. Neuroendocrine tumor cell lines of pulmonary and gastrointestinal origin are surprisingly sensitive to PKC delta inhibition by the compounds of the invention. The invention is further directed to methods, compositions and kits containing compounds of the formulas (Ia), (IIa), (IIIa), (IVa), and (V) as disclosed and described in FIGS. 11 and 12.

Abstract: The biosynthesis of fungal bicyclo[2.2.2]diazaoctane indole alkaloids with a wide spectrum of biological activities have attracted increasing interest. Their intriguing mode of assembly has long been proposed to feature a non-ribosomal peptide synthetase, a presumed intramolecular Diels-Alderase, a variant number of prenyltransferases, and a series of oxidases responsible for the diverse tailoring modifications of their cyclodipeptide-based structural core. Until recently, the details of these biosynthetic pathways have remained largely unknown due to lack of information on the fungal derived biosynthetic gene clusters. Herein, we report a comparative analysis of four natural product metabolic systems of a select group of bicyclo[2.2.2]diazaoctane indole alkaloids including (+)/(?)-notoamide, paraherquamide and malbrancheamide, in which we propose an enzyme for each step in the biosynthetic pathway based on deep annotation and on-going biochemical studies.

Abstract: The present invention is directed to the biosynthetic pathway for a nonribosomal peptide synthetase (NRPS) derived drug and analogs thereof. The invention also discloses polynucleotide sequences useful for heterologous expression in a convenient microbial host for the synthesis of the NRPS derived drug.

Abstract: The present invention relates to a method of making a paper product having improved printing characteristics. This is achieved by forming a fibrous substrate, and applying a surface treatment which comprises an aqueous composition. Notably, the aqueous composition includes surface enhanced pulp fibers, with the placement of the surface enhanced pulp fibers optimizing their functionality, with surface placement by use of a paper machine size press desirably facilitating a reduction in the typical starch usage. The present method comprising the steps of providing a aqueous slurry comprising a blend of cellulosic fibers and water and dewatering the aqueous slurry of cellulosic fibers and water to form a fibrous substrate.

Abstract: The invention is directed to compounds that are specific inhibitors of PKC delta, and methods and compositions for the treatment and prevention of cancers and other disorders. Compositions comprising compounds of the invention are used to treat cancers such as, for example, carcinoid and neuroendocrine tumors, malignant melanomas, pancreatic, gastrointestinal and lung cancers. Neuroendocrine tumor cell lines of pulmonary and gastrointestinal origin are surprisingly sensitive to PKC delta inhibition by the compounds of the invention. The invention is further directed to methods, compositions and kits containing compounds of the formulas (Ia), (IIa), (IIIa), (IVa), and (V) as disclosed and described in FIGS. 11 and 12.

Abstract: The invention is directed to compounds that are specific inhibitors of PKC delta, and methods and compositions for the treatment and prevention of cancers and other disorders. Compositions comprising compounds of the invention are used to treat cancers such as, for example, carcinoid and neuroendocrine tumors, malignant melanomas, pancreatic, gastrointestinal and lung cancers. Neuroendocrine tumor cell lines of pulmonary and gastrointestinal origin are surprisingly sensitive to PKC delta inhibition by the compounds of the invention. The invention is further directed to methods, compositions and kits containing compounds of the formulas (Ia), (IIa), (IIIa), (IVa), and (V) as disclosed and described in FIGS. 11 and 12.

Abstract: The invention is directed to compounds that are specific inhibitors of PKC delta, and methods and compositions for the treatment and prevention of cancers and other disorders. Compositions comprising compounds of the invention are used to treat cancers such as, for example, carcinoid and neuroendocrine tumors, malignant melanomas, pancreatic, gastrointestinal and lung cancers. Neuroendocrine tumor cell lines of pulmonary and gastrointestinal origin are surprisingly sensitive to PKC delta inhibition by the compounds of the invention. The invention is further directed to methods, compositions and kits containing compounds of the formulas (Ia), (IIa), (IIIa), (IVa), and (V) as disclosed and described in FIGS. 11 and 12.